ID16878A - Turunan indol yang bermanfaat untuk pengobatan - Google Patents

Turunan indol yang bermanfaat untuk pengobatan

Info

Publication number
ID16878A
ID16878A IDP971517A ID971517A ID16878A ID 16878 A ID16878 A ID 16878A ID P971517 A IDP971517 A ID P971517A ID 971517 A ID971517 A ID 971517A ID 16878 A ID16878 A ID 16878A
Authority
ID
Indonesia
Prior art keywords
indol
derives
useful
treatment
indol derives
Prior art date
Application number
IDP971517A
Other languages
English (en)
Inventor
David James Rawson
Kevin Neil Dack
Roger Peter Dickinson
Kim James
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID16878A publication Critical patent/ID16878A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IDP971517A 1996-05-09 1997-05-07 Turunan indol yang bermanfaat untuk pengobatan ID16878A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
ID16878A true ID16878A (id) 1997-11-20

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971517A ID16878A (id) 1996-05-09 1997-05-07 Turunan indol yang bermanfaat untuk pengobatan

Country Status (43)

Country Link
US (4) US6017945A (id)
EP (1) EP0901470B1 (id)
JP (1) JP3245179B2 (id)
KR (1) KR100331217B1 (id)
CN (1) CN1124262C (id)
AP (1) AP830A (id)
AR (1) AR007030A1 (id)
AT (1) ATE263151T1 (id)
AU (1) AU717849B2 (id)
BG (1) BG102873A (id)
BR (1) BR9709072A (id)
CA (1) CA2253876A1 (id)
CO (1) CO4650036A1 (id)
CZ (1) CZ292928B6 (id)
DE (1) DE69728392T2 (id)
DK (1) DK0901470T3 (id)
DZ (1) DZ2227A1 (id)
EA (1) EA001471B1 (id)
ES (1) ES2218675T3 (id)
GB (1) GB9609641D0 (id)
HK (1) HK1019149A1 (id)
HN (1) HN1997000058A (id)
HR (1) HRP970249B1 (id)
HU (1) HUP9901245A3 (id)
ID (1) ID16878A (id)
IL (1) IL125903A0 (id)
IS (1) IS1856B (id)
MA (1) MA26428A1 (id)
NO (1) NO312547B1 (id)
NZ (1) NZ332640A (id)
OA (1) OA10896A (id)
PE (1) PE65098A1 (id)
PL (1) PL329725A1 (id)
PT (1) PT901470E (id)
SI (1) SI0901470T1 (id)
SK (1) SK150398A3 (id)
TN (1) TNSN97078A1 (id)
TR (1) TR199802269T2 (id)
TW (1) TW491838B (id)
UA (1) UA50767C2 (id)
UY (1) UY24546A1 (id)
WO (1) WO1997043260A1 (id)
ZA (1) ZA973963B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) * 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
AU763618B2 (en) 1999-02-10 2003-07-31 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
ATE367812T1 (de) 2001-06-20 2007-08-15 Wyeth Corp Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
ES2266907T3 (es) 2002-12-10 2007-03-01 Wyeth Derivados sustituidos del acido 3-carbonil-indol-1-il-acetico como inhibidor del activador del plasminogeno-1 (pal-1).
AU2003296324A1 (en) 2002-12-10 2004-06-30 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7056943B2 (en) 2002-12-10 2006-06-06 Wyeth Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
AU2003297727A1 (en) 2002-12-10 2004-06-30 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CN1742007A (zh) * 2003-01-22 2006-03-01 伊莱利利公司 甾族激素核受体的吲哚衍生物调控剂
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
MX2007002178A (es) 2004-08-23 2007-04-02 Wyeth Corp Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
CN101263115A (zh) 2005-08-17 2008-09-10 惠氏公司 经取代吲哚和其用途
US20100022568A1 (en) * 2006-04-13 2010-01-28 Actelion Pharmaceeuticals Ltd. Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
CN113784962A (zh) 2019-02-27 2021-12-10 加利福尼亚大学董事会 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297887A (id) * 1962-09-14
GB1255518A (en) * 1968-10-08 1971-12-01 Sumitomo Chemical Co 2-indolylacetic acid derivatives and process for production thereof
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された二環式アリール化合物
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DK0617001T3 (da) * 1993-03-19 2000-04-17 Merck & Co Inc Phenoxyphenyleddikesyrederivater
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
AU2697897A (en) 1997-12-05
CA2253876A1 (en) 1997-11-20
TW491838B (en) 2002-06-21
AR007030A1 (es) 1999-10-13
AU717849B2 (en) 2000-04-06
TNSN97078A1 (fr) 2005-03-15
GB9609641D0 (en) 1996-07-10
US6384070B2 (en) 2002-05-07
NO985225D0 (no) 1998-11-09
EA199800908A1 (ru) 1999-06-24
PL329725A1 (en) 1999-04-12
CO4650036A1 (es) 1998-09-03
ES2218675T3 (es) 2004-11-16
PE65098A1 (es) 1998-10-29
CZ358298A3 (cs) 1999-08-11
DE69728392T2 (de) 2005-01-13
CN1124262C (zh) 2003-10-15
BR9709072A (pt) 1999-08-03
ATE263151T1 (de) 2004-04-15
JPH11508285A (ja) 1999-07-21
NZ332640A (en) 2001-03-30
HN1997000058A (es) 1997-06-26
UA50767C2 (uk) 2002-11-15
EP0901470A1 (en) 1999-03-17
BG102873A (en) 1999-11-30
KR20000010879A (ko) 2000-02-25
US6017945A (en) 2000-01-25
ZA973963B (en) 1998-11-09
DK0901470T3 (da) 2004-07-12
MA26428A1 (fr) 2004-12-20
SI0901470T1 (en) 2004-08-31
HRP970249B1 (en) 2003-06-30
HUP9901245A2 (hu) 1999-08-30
UY24546A1 (es) 2000-09-29
DE69728392D1 (de) 2004-05-06
US20010014677A1 (en) 2001-08-16
IL125903A0 (en) 1999-04-11
HUP9901245A3 (en) 2002-01-28
OA10896A (en) 2001-10-11
AP9700982A0 (en) 1997-07-31
HRP970249A2 (en) 1998-06-30
AP830A (en) 2000-05-03
US6306852B1 (en) 2001-10-23
DZ2227A1 (fr) 2002-12-25
NO985225L (no) 1998-11-09
US6136843A (en) 2000-10-24
CZ292928B6 (cs) 2004-01-14
EP0901470B1 (en) 2004-03-31
IS1856B (is) 2003-02-21
EA001471B1 (ru) 2001-04-23
HK1019149A1 (en) 2000-01-14
PT901470E (pt) 2004-07-30
TR199802269T2 (xx) 2001-12-21
WO1997043260A1 (en) 1997-11-20
JP3245179B2 (ja) 2002-01-07
IS4838A (is) 1998-08-28
CN1216531A (zh) 1999-05-12
SK150398A3 (en) 1999-03-12
KR100331217B1 (ko) 2002-05-09
NO312547B1 (no) 2002-05-27

Similar Documents

Publication Publication Date Title
ID16878A (id) Turunan indol yang bermanfaat untuk pengobatan
NO983266D0 (no) Distribuert Behandling
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO990531L (no) Partikkel-siktanordning
DK0835637T3 (da) Behandlingstilbehør til endeskop
DK0834278T3 (da) Behandlingstilbehør til endoskop
NO992237D0 (no) Vannbehandlingsprosess
IS4812A (is) Samsett meðferð fyrir beingisnun
DE69623437D1 (de) Wasserbehandlungsapparat
DK0951447T3 (da) Vandbehandling
DE69700307D1 (de) Ersatzverarbeitungsverfahren
DE69621432D1 (de) Bettvorrichtung
DE69705041D1 (de) Reinigungsverfahren
DE69704990D1 (de) Ozonerzeuger
DE69812725D1 (de) Laserbehandlungsgerät
DE69733470D1 (de) Laserbearbeitung
NO990449D0 (no) FremgangsmÕte for hydrogenbehandling
PT883718E (pt) Aparelho de dragagem
ID21770A (id) Plester yang mengandung felbinak
ID17723A (id) Senyawa untuk pengobatan
NO993019D0 (no) Elektrolyseapparat
DE69907803D1 (de) Laserbehandlungsgerät
NO983263D0 (no) Distribuert behandling
DE69718808D1 (de) Plasmabehandlungsmethode
IS4789A (is) Meðferðarefnasambönd